These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5018311)

  • 1. Dextrose and sorbitol as diluents for continuous intravenous heparin infusion.
    Chessells JM; Braithwaite TA; Chamberlain DA
    Br Med J; 1972 Apr; 2(5805):81-2. PubMed ID: 5018311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous infusions of heparin and penicillins.
    Jacobs J; Kletter D; Superstine E; Hill KR; Lynn B; Webb RA
    J Clin Pathol; 1973 Oct; 26(10):742-6. PubMed ID: 4750455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin stability: effects of diluent, heparin activity, container, and pH.
    Goodall KT; Chooi CC; Gallus AS
    J Clin Pathol; 1980 Dec; 33(12):1206-11. PubMed ID: 7451668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin stability in dextrose solutions [proceedings].
    Anderson W; Harthill JE; Couper IA; Stafford S
    J Pharm Pharmacol; 1977 Dec; 29 Suppl():31P. PubMed ID: 22661
    [No Abstract]   [Full Text] [Related]  

  • 5. Heparin elimination following continuous infusion during intra-aortic balloon counterpulsation.
    Jacob AS; Steingart RH; Schweger MJ
    Cathet Cardiovasc Diagn; 1985; 11(4):389-92. PubMed ID: 4042156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of heparin. II. Studies of time dependence in rats.
    Bjornsson TD; Levy G
    J Pharmacol Exp Ther; 1979 Aug; 210(2):243-6. PubMed ID: 458631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility and stability of diazepam injection following dilution with intravenous fluids.
    Morris ME
    Am J Hosp Pharm; 1978 Jun; 35(6):669-72. PubMed ID: 665679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of heparin therapy: Controlled prospective trial.
    Salzman EW; Deykin D; Shapiro RM; Rosenberg R
    N Engl J Med; 1975 May; 292(20):1046-50. PubMed ID: 1091856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory control of continuous intravenous heparin therapy with Howel time and activated partial thromboplastin time. A prospective, randomized and blind study.
    Almazan A; Lozano F; Ramos M; Rodriguez-Moran M; Gomez-Alonso A
    Angiology; 1985 Jun; 36(6):363-9. PubMed ID: 4025944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stability of amoxycillin sodium in intravenous infusion fluids.
    Cook B; Hill SA; Lynn B
    J Clin Hosp Pharm; 1982 Dec; 7(4):245-50. PubMed ID: 7161398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of heparin anticoagulant activity over time in parenteral nutrition solutions.
    Hensrud DD; Burritt MF; Hall LG
    JPEN J Parenter Enteral Nutr; 1996; 20(3):219-21. PubMed ID: 8776697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the continuous administration of fat emulsion on the infiltration of intravenous lines in infants receiving peripheral parenteral nutrition solutions.
    Phelps SJ; Cochran EB
    JPEN J Parenter Enteral Nutr; 1989; 13(6):628-32. PubMed ID: 2614864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation by constant subcutaneous heparin infusion.
    Parrilla N; Ansell J
    Thromb Haemost; 1982 Feb; 47(1):1-2. PubMed ID: 7071800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anticoagulant activity of heparins in dextrose solutions.
    Anderson W; Harthill JE
    J Pharm Pharmacol; 1982 Feb; 34(2):90-6. PubMed ID: 6121887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin therapy by continuous intravenous infusion.
    Cacace L; Swanson M
    Am J Hosp Pharm; 1972 Apr; 29(4):294. PubMed ID: 5025255
    [No Abstract]   [Full Text] [Related]  

  • 16. Heparin therapy by continuous intravenous infusion.
    Ashby DM
    Am J Hosp Pharm; 1972 Apr; 29(4):293. PubMed ID: 5025254
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term, continuous intravenous heparin administration by an implantable infusion pump in ambulatory patients with recurrent venous thrombosis.
    Buchwald H; Rohde TD; Schneider PD; Varco RL; Blackshear PJ
    Surgery; 1980 Oct; 88(4):507-16. PubMed ID: 7423373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of heparin sodium and dopamine hydrochloride in admixtures studied by microcalorimetry.
    Pereira-Rosario R; Utamura T; Perrin JH
    Am J Hosp Pharm; 1988 Jun; 45(6):1350-2. PubMed ID: 3414704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of the Braun Unita I and perfusor to disposable syringes for continuous intravenous heparin infusion.
    Ramsay DM
    J Clin Pathol; 1972 May; 25(5):456-7. PubMed ID: 5046076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.